Woodline Partners »

Aktis Oncology shares owned by Woodline Partners

Quarter-by-quarter ownership of Aktis Oncology shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Aktis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Aktis Oncology held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aktis Oncology by Woodline Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.8M 100k 17.89

More positions owned by Woodline Partners

NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Johnson & Johnson (JNJ)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Revolution Medicines (RVMD)
Verizon Communications (VZ)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Applied Materials (AMAT)
Texas Instruments Incorporated (TXN)

View all positions for Woodline Partners

Top funds holding Aktis Oncology

MPM Oncology Impact Management
EcoR1 Capital
BlackRock
RA Capital Management
Henderson Group
Baker Bros. Advisors
Octagon Capital Advisors
Merck & Co
Vanguard Capital Management
Geode Capital Management
Avidity Partners Management
AH Capital Management
UBS Group
Arrowpoint Asset Management
Alyeska Investment Group

View all funds holding Aktis Oncology